Download PDF
Synlett 2007(12): 1951-1953  
DOI: 10.1055/s-2007-984536
LETTER
© Georg Thieme Verlag Stuttgart · New York

Divergent Synthesis of Linear and Angular Furocoumarin Acetic Acids from Phloroglucinol

Giovanna Delogu*a, Carmen Picciaua, Elias Quezadaa,b, Lourdes Santanab, Eugenio Uriarteb
a Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Cagliari, Via Ospedale 72, 09124 Cagliari, Italy
Fax: +39(070)6758553; e-Mail: delogug@unica.it;
b Departamento de Química Orgánica, Facultad de Farmacia, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain
Further Information

Publication History

Received 23 April 2007
Publication Date:
27 June 2007 (online)

    Permissions and Reprints All articles of this category

Abstract

Linear and angular furocoumarins can be obtained starting from phloroglucinol in a versatile, simple, direct, and efficient way, as demonstrated in the divergent syntheses described here. The key step is the alkali-mediated rearrangement of 4-halomethylcoumarins to benzofuran-3-acetic acids via α,β-unsaturated acids and the key intermediates are benzodipyrones, which, depending on their substitution, can either give or fail to give the ring-contraction reaction.

Key words

Pechmann reaction - furocoumarin acetic acids - ring-contraction reaction - divergent synthesis

    References and Notes

  • 1 Santana L. Uriarte E. Roleira F. Milhazes N. Borges F. Curr. Med. Chem.  2004,  11:  3239 
    Google Scholar
  • 2 Dalla Via L. Marciani-Magno S. Curr. Med. Chem.  2001,  8:  1405 
    Google Scholar
  • 3a Fall Y. Santana L. Teijeira M. Uriarte E. Heterocycles  1995,  41:  647 
    CrossrefGoogle Scholar
  • 3b Santana L. Teijeira M. Uriarte E. Teran C. Linares B. Villar R. Laguna R. Cano E. Eur. J. Pharm. Sci.  1999,  7:  161 
    CrossrefGoogle Scholar
  • 4a Willis I. Menter JM. J. Nat. Cancer Inst.  1984,  66:  143 
    Google Scholar
  • 4b Greenman WM, Grass JA, Talib S, Stassinopoulos A, Hei DJ, and Hearst JE. inventors; WO  9903976 A2 19990128.  ; Chem. Abstr. 1999, 130, 152548
  • 4c Cook D, Merritt J, Nerio A, Rapoport H, Stassinopoulos A, Wollowitz S, and Matejovic J. inventors; WO  9830545 A1 19980716.  ; Chem. Abstr. 1998, 129, 136107
  • 4d Kontogiorgis C. Hadjipavlou-Litina D. J. Enzyme Inhib. Med. Chem.  2003,  18:  63 
    Google Scholar
  • 5a Zagotto G. Gia O. Baccichetti F. Uriarte E. Palumbo M. Photochem. Photobiol.  1993,  58:  486 
    CrossrefGoogle Scholar
  • 5b Smitha G. Sanjeeva Reddy Cc. Synth. Commun.  2004,  34:  3997 
    CrossrefGoogle Scholar
  • 5c Valizadeh H. Shockravi A. Tetrahedron Lett.  2005,  46:  3501 
    CrossrefGoogle Scholar
  • 5d Sharma GVM. Reddy JJ. Lakshmi PS. Krishna PR. Tetrahedron Lett.  2005,  46:  6119 
    CrossrefGoogle Scholar
  • 6 Borges F. Roleira F. Milhazes N. Santana L. Uriarte E. Curr. Med. Chem.  2005,  12:  887 
    CrossrefPubMedGoogle Scholar
  • 8a Kravtchenko DV. Chibisova TA. Traven VF. Russ. J. Org. Chem.  1999,  35:  899 
    CrossrefGoogle Scholar
  • 8b González-Gómez JC. Santana L. Uriarte E. Tetrahedron  2003,  59:  8171 
    CrossrefGoogle Scholar
7

A solution of 1 (300 mg, 2.4 mmol) in H2SO4 was stirred at r.t. for 20 min. Then, ethyl 4-chloroacetoacetate (1.60 mL, 1.95 g, 11.89 mmol) was added dropwise and the reaction was stirred at r.t. overnight. Ice (50 mL) was added, the solution was filtered, and the precipitate was washed with cold H2O until the washings were pH 7. The residue was purified by silica gel column chromatography (hexane-EtOAc, 4:1 to 3:2) to afford 2 (16 mg, 2.5% yield), 3 (104 mg, 15.0% yield), and 4 (220 mg, 41.0% yield), all as pure white solids.
10-Chloromethyl-8H-8-oxofuro[4,3,2-e]pyran[3,2-g]coumarin(2): mp 243-244 °C. IR (KBr): 2960, 1684, 1639, 1590, 1390, 1208, 1109, 1074, 856 cm-1. 1H NMR (500 MHz, DMSO-d 6): δ = 4.93 (s, 2 H, CH2Cl), 5.90 (d, J = 2.1 Hz, 2 H, H-2), 6.20 (t, J = 2.1 Hz, 1 H, H-3), 6.56 (s, 1 H, H-9), 7.03 (s, 1 H, H-6). MS: m/z (%) = 292 (2) [M + 2]+, 290 (15) [M+], 178 (86), 163 (69), 135 (10).
10-Chloromethyl-8H-8-oxofuro[4,3,2-d,e]pyran[3,2-h]coumarin(3): mp 266-267 °C. IR (KBr): 2960, 1684, 1639, 1590, 1390, 1208, 1109, 1074, 856 cm-1. 1H NMR (500 MHz, DMSO-d 6): δ = 5.11 (s, 2 H, CH2Cl), 5.82 (d, J = 2.0 Hz, 2 H, H-4), 6.31 (t, J = 2.0 Hz, 1 H, H-3), 6.58 (s, 1 H, H-9), 7.03 (s, 1 H, H-6). MS: m/z (%) = 292 (0.5) [M + 2]+, 290 (3) [M+] , 220 (1.6), 142 (1.7), 104 (3), 79 (25), 54 (51), 46 (80), 33 (100).

9

Synthesis of 3,5-Bis(carboxymethyl)-4-hydroxyfuro[3,2- f ]benzofuran ( 5)
A mixture of 3 (100 mg, 0.344 mmol) in 0.1 N NaOH (10 mL) was stirred at 0 °C for 30 min. Then, 3 N HCl was added to give pH 6.0 at the same temperature. The resulting brown precipitate was filtered off and washed with cold H2O until the washings were pH 7. The residue was purified by silica gel column chromatography (CH2Cl2-MeOH, 9:1 to 4:1) to give 5 (77 mg, 78.0%); mp 147 °C (dec.). IR (KBr): 3520, 2949, 2840, 1746, 1620, 1599, 1422, 1128, 1080, 830 cm-1. 1H NMR (DMSO-d 6): δ = 3.74 and 3.77 (2 s, 2 + 2 H, 2 CH2), 6.73 (s, 1 H, H-8), 7.67 and 7.69 (2 s, 1 + 1 H, H-2 and H-6), 9.99 (br s, 1 H, OH), 12.31 (br s, 2 H, 2 COOH). MS: m/z (%) = 290 (0.2) [M+], 261 (12), 247 (58), 231 (12), 203 (100), 201 (15), 164 (5).

10

6-Carboxymethyl-5-hydroxy-4-hydroxymethylfuro[3,2-g]coumarin (7): mp 290 °C (dec.). IR (KBr): 3550, 2930, 2800, 1715, 1595, 1430, 1100, 1080, 835 cm-1. 1H NMR (250 MHz, DMSO-d 6): δ = 3.84 (s, 2 H, CH2CO), 4.76 (s, 2 H, CH 2OH), 6.05 (s, 1 H, H-3), 6.88 (s, 1 H, H-9), 7.96 (s, 1 H, H-7), 9.45 (br s, 1 H, OH), 11.05 (br s, 2 H, 2 OH). MS: m/z (%) = 291 (9) [M + 1]+, 290 (100) [M+], 272 (15), 246 (20), 205 (10).

11

9-Carboxymethyl-5-hydroxy-4-hydroxymethylfuro[2,3-h]coumarin (10): mp 285 °C (dec.). IR (KBr): 2949, 2840, 1716, 1599, 1432, 1108, 1088, 832 cm-1. 1H NMR (250 MHz, DMSO-d 6): δ = 3.80 (s, 2 H, CH2CO), 4.72 (s, 2 H, CH 2OH), 6.08 (s, 1 H, H-3), 6.79 (s, 1 H, H-6), 7.58 (s, 1 H, H-8), 10.80 (br s, 3 H, 3 OH). MS: m/z (%) = 291 (8) [M + 1]+, 290 (100) [M+], 272 (18), 246 (9), 228 (15).